AZTR Stock Catalyst: Azitra Announces Positive Preclinical Data for ATR-01 Program

Oct 20, 2025 · 8:02am ET

Company releases promising results for treatment of Ichthyosis Vulgaris.

Max move

+78.8%

High of day $1.26

Sparker timei

8:02am ET

AZTR · Oct 20, 2025

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Azitra, Inc. (XASE: AZTR) announced positive preclinical data for its ATR-01 program, which is designed to treat Ichthyosis Vulgaris. The announcement was made following successful laboratory tests that demonstrated the potential efficacy of the treatment.

The company did not provide specific figures or comparisons in this announcement. The ATR-01 program now moves closer to potential clinical trials, pending further regulatory and internal reviews.

Azitra Inc. has a free float of 3,506,800 shares and 5,405,000 shares outstanding.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time AZTR sparks.

Download Sniper App →

Catch the next AZTR-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →